U.S. healthcare facilities spend over $10 billion annually to dispose of biohazardous waste materials. This waste material creates exposure risks to employees and patients and is harming our environment.
Every year about 600,000 to 800,000 needlestick incidents take place in healthcare. Roughly 16,000 involve needles containing infected blood product. The most serious pathogens involved are HIV, Hepatitis B and Hepatitis C. The cost of needlestick injury follow-up in the U.S. per incident is around $3,000. A total of $3 billion is spent annually in the U.S. on needlestick injuries.
Over 8 billion syringes are used in the U.S. per year. That equates to thousands of tons of polypropylene plastic that is being incinerated and dumped into landfills. Medical waste incinerators are one of the nation’s leading emissions sources of persistent, toxic, bioaccumulative pollutants such as dioxins and mercury. In addition, the transportation that hauls regulated medical waste long distances to incinerators also emit toxic pollutants. Exposure to these pollutants threatens public health.
The sharpsPRO operates a low heat zero emission process that converts biohazardous waste into a recyclable non-hazardous by-product which eliminates incineration and emission of toxic pollutants.
The main benefits of using the sharpsPRO are SAFETY, SAVINGS and SUSTAINABILITY.
By processing sharps medical waste on-site greatly reduces the chances of needlestick.
The sharpsPRO can drastically reduce or eliminate monthly biohazardous waste collection fees.
The sharpsPRO produces a non-hazardous recyclable by-product. Recycling reduces the consumption of raw, finite resources, such as oil and propene gas to generate new plastic. There is an 88% reduction in energy usage if plastic is produced from plastic.